Tirz - GLP1

Tirzepatide is a prescription injectable medicine used for type 2 diabetes and, in some countries/brands, chronic weight management. It works on two hormone pathways, GIP and GLP-1, which affect appetite, fullness, insulin response and blood sugar control.

Main benefits people may experience:

1. Weight loss
Tirzepatide can reduce appetite, increase fullness, and help people eat less. In clinical trials for obesity/overweight, people using tirzepatide with diet and exercise lost significantly more weight than placebo. 

2. Better blood sugar control
For people with type 2 diabetes, tirzepatide can lower HbA1c, which is the average blood sugar marker over roughly 2–3 months. NICE states clinical trial results showed reductions in blood glucose and body weight compared with placebo, insulin therapy or semaglutide.

3. Reduced appetite and cravings
Many people report feeling fuller faster and having less “food noise.” This is one of the main reasons it helps with weight loss.

4. May improve waist measurement and metabolic markers
Because it can support weight loss and glucose control, it may also improve some weight-related health markers such as waist circumference, cholesterol, blood pressure or fatty liver markers in some people — but this depends on the individual and should be monitored by a doctor.

5. Once-weekly dosing
Prescription tirzepatide is generally used as a once-weekly injection, which can be easier than daily treatments. The official Mounjaro prescribing information describes once-weekly subcutaneous dosing for type 2 diabetes.